259 related articles for article (PubMed ID: 2300897)
1. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
2. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines.
Weber CJ; O'Dorisio TM; McDonald TJ; Howe B; Koschitzky T; Merriam L
Surgery; 1989 Dec; 106(6):1134-9; discussion 1139-40. PubMed ID: 2588117
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
[TBL] [Abstract][Full Text] [Related]
6. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
7. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.
Modigliani E; Casanova S; Chayvialle JA; Bernard C; Franc B; Cohen R; Calmettes C
J Clin Endocrinol Metab; 1990 Oct; 71(4):831-5. PubMed ID: 1976126
[TBL] [Abstract][Full Text] [Related]
9. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
10. Post-translation processing of neurohormonal peptide precursors in a human medullary thyroid carcinoma.
Conlon JM
Horm Metab Res Suppl; 1989; 21():12-5. PubMed ID: 2572526
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
12. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of thyroid medullary carcinoma TT cell line.
Zabel M; Grzeszkowiak J
Histol Histopathol; 1997 Jan; 12(1):283-9. PubMed ID: 9046062
[TBL] [Abstract][Full Text] [Related]
14. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
Gautvik KM
Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
[TBL] [Abstract][Full Text] [Related]
15. [Immuno-histochemical study of medullary thyroid carcinoma].
Bessho T
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):872-84. PubMed ID: 2890090
[TBL] [Abstract][Full Text] [Related]
16. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
17. Detection of calcitonin and calcitonin gene-related peptide mRNA in human medullary thyroid carcinoma. A retrospective study.
Denijn M; De Weger RA; Van Unnik JA; Den Otter W; Lips CJ
J Pathol; 1993 Jan; 169(1):53-60. PubMed ID: 8433214
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma.
Maruno K; Yamaguchi K; Abe K; Suzuki M; Saijo N; Mishima Y; Yanaihara N; Shimosato Y
Cancer Res; 1989 Feb; 49(3):629-32. PubMed ID: 2535962
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
Holm R; Sobrinho-Simões M; Nesland JM; Sambade C; Johannessen JV
Lab Invest; 1987 Sep; 57(3):258-68. PubMed ID: 3626517
[TBL] [Abstract][Full Text] [Related]
20. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]